Escape mutants of newcastle disease virus as marker vaccines
AssigneeWyeth
InventorsHarmen J. Geerligs, Ian Hamer Brown, Dennis John Alexander, Michael Sinclair Collins
Life of this patent
Estimating the term…
Abstract
A vaccine against Newcastle Disease contains one or more mutant immunogens of the NDW strain. The mutant immunogen lacks the antigenic binding site on the F glycoprotein which is recognized by the monoclonal antibody mAb 54. Reagent kits and assay methods help to distinguish vaccinated members of a poultry flock from those that may have been infected with wild-type Newcastle Disease virus.
Claims1
A vaccine against Newcastle Disease virus, comprising about 100–109 EID50 of a mutant immunogen from the NDW strain of the Newcastle Disease virus, wherein said mutant immunogen lacks the antigenic binding site on the F glycoprotein recognized by the monoclonal antibody designated Ab 54, wherein said mutant immunogen is identified as p. 13, and is deposited at the CNCM in Paris, France under accession number I-2928.
Dependencies are inferred from the claim text.